Similar articles

• The application of immunotherapy to the treatment of cancer.

  Powles RL. Powles RL. Pharmacol Ther. 1979;4(2):281-306. doi: 10.1016/0163-7258(79)90139-6. Pharmacol Ther. 1979. PMID: 386383 Review. No abstract available.
• [Immunotherapy of cancer: evolution of concepts and clinical advances].

  Baldwin RW. Baldwin RW. Rev Prat. 1980 Jan 21;30(5):221-4, 227-8. Rev Prat. 1980. PMID: 6929557 French. No abstract available.
• [Management of acute leukemias and linphosarcomas with active immunotherapy (author's transl)].

  Mathe G, Amiel JL, Schwarsenberg L, Hyat M, Pouillart P, Schenider M, Cattan A, Jasmin C, Belpomme D, Schulmberger JR, De Vassal F, Musset M, Misset JL. Mathe G, et al. Folia Clin Int (Barc). 1975 Mar;25(3):131-51. Folia Clin Int (Barc). 1975. PMID: 1056311 Spanish. No abstract available.
• Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants.

  Mastrangelo MJ, Berd D, Bellet RE. Mastrangelo MJ, et al. Ann N Y Acad Sci. 1976;277(00):94-123. doi: 10.1111/j.1749-6632.1976.tb41693.x. Ann N Y Acad Sci. 1976. PMID: 793490 Review. No abstract available.
• Immunotherapy in the treatment of acute leukaemia.

  Whittaker JA. Whittaker JA. Br J Haematol. 1980 Jun;45(2):187-93. doi: 10.1111/j.1365-2141.1980.tb07137.x. Br J Haematol. 1980. PMID: 6934004 No abstract available.